Natixis Advisors LLC Purchases 53,185 Shares of Ventas, Inc. $VTR

Natixis Advisors LLC lifted its position in shares of Ventas, Inc. (NYSE:VTR) by 30.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 228,251 shares of the real estate investment trust’s stock after purchasing an additional 53,185 shares during the quarter. Natixis Advisors LLC’s holdings in Ventas were worth $15,976,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Cloud Capital Management LLC bought a new stake in shares of Ventas in the 3rd quarter valued at $25,000. True Wealth Design LLC lifted its holdings in Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after acquiring an additional 405 shares in the last quarter. ORG Partners LLC lifted its holdings in Ventas by 76.1% during the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock worth $32,000 after acquiring an additional 197 shares in the last quarter. Wilmington Savings Fund Society FSB grew its stake in Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 180 shares during the period. Finally, Elevation Point Wealth Partners LLC acquired a new position in Ventas in the second quarter valued at about $35,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insider Transactions at Ventas

In other news, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president directly owned 72,755 shares in the company, valued at $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the sale, the chief executive officer directly owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 86,106 shares of company stock valued at $6,931,397 in the last ninety days. 0.80% of the stock is currently owned by corporate insiders.

Ventas Stock Performance

VTR opened at $86.14 on Friday. The company has a market capitalization of $40.91 billion, a price-to-earnings ratio of 159.51, a P/E/G ratio of 2.09 and a beta of 0.73. The business’s 50-day moving average price is $81.27 and its two-hundred day moving average price is $76.19. Ventas, Inc. has a 1 year low of $60.15 and a 1 year high of $87.87. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the company earned $0.81 earnings per share. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts expect that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This is an increase from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Ventas’s payout ratio is currently 355.56%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on VTR. Argus set a $88.00 price target on Ventas in a research report on Tuesday, February 10th. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Cantor Fitzgerald reissued an “overweight” rating and set a $93.00 target price on shares of Ventas in a research note on Monday, February 9th. Scotiabank raised their target price on shares of Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a report on Monday, March 2nd. Finally, Mizuho lifted their price target on shares of Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a research note on Wednesday, March 4th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $89.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.